CRIS
Curis Inc
Price:  
8.13 
USD
Volume:  
24,862.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CRIS EV/EBITDA

-2184.2%
Upside

As of 2024-06-17, the EV/EBITDA ratio of Curis Inc (CRIS) is -0.36. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CRIS's latest enterprise value is 17.93 mil USD. CRIS's TTM EBITDA according to its financial statements is -50.27 mil USD. Dividing these 2 quantities gives us the above CRIS EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 14.6x - 22.9x 18.2x
Forward P/E multiples 19.5x - 24.0x 22.7x
Fair Price (161.51) - (190.19) (169.45)
Upside -2086.6% - -2439.3% -2184.2%
8.13 USD
Stock Price
(169.45) USD
Fair Price

CRIS EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-06-14 -0.36
2024-06-13 -0.40
2024-06-12 -0.44
2024-06-11 -0.41
2024-06-10 -0.34
2024-06-07 -0.44
2024-06-06 -0.54
2024-06-05 -0.52
2024-06-04 -0.53
2024-06-03 -0.59
2024-05-31 -0.62
2024-05-30 -0.65
2024-05-29 -0.65
2024-05-28 -0.71
2024-05-24 -0.72
2024-05-23 -0.71
2024-05-22 -0.67
2024-05-21 -0.67
2024-05-20 -0.64
2024-05-17 -0.79
2024-05-16 -0.88
2024-05-15 -0.93
2024-05-14 -1.24
2024-05-13 -1.24
2024-05-10 -1.25
2024-05-09 -1.34
2024-05-08 -1.32
2024-05-07 -1.30
2024-05-06 -1.30
2024-05-03 -1.32
2024-05-02 -1.34
2024-05-01 -1.28
2024-04-30 -1.20
2024-04-29 -1.13
2024-04-26 -1.10
2024-04-25 -1.11
2024-04-24 -1.13
2024-04-23 -1.16
2024-04-22 -1.14
2024-04-19 -1.08
2024-04-18 -1.19
2024-04-17 -1.27
2024-04-16 -1.19
2024-04-15 -1.11
2024-04-12 -1.19
2024-04-11 -1.27
2024-04-10 -1.19
2024-04-09 -1.23
2024-04-08 -1.34
2024-04-05 -1.37